These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 15018081)
1. [Therapeutic options and controversies in the management of prostate cancer]. Peyromaure M; Thiounn N Rev Prat; 2003 Dec; 53(20):2263-7. PubMed ID: 15018081 [TBL] [Abstract][Full Text] [Related]
2. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow. Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849 [TBL] [Abstract][Full Text] [Related]
3. [Established and new urological therapeutic options in the management of prostate carcinoma]. Michel MS; Trojan L; Knoll T; Bross S; Alken P Radiologe; 2003 Jun; 43(6):441-7. PubMed ID: 12827258 [TBL] [Abstract][Full Text] [Related]
8. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option. Allen GW; Howard AR; Jarrard DF; Ritter MA Cancer; 2007 Oct; 110(7):1405-16. PubMed ID: 17685384 [TBL] [Abstract][Full Text] [Related]
9. Prostate cancer therapy: standard management, new options and experimental approaches. Trojan L; Kiknavelidze K; Knoll T; Alken P; Michel MS Anticancer Res; 2005; 25(1B):551-61. PubMed ID: 15816628 [TBL] [Abstract][Full Text] [Related]
10. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537 [TBL] [Abstract][Full Text] [Related]
11. [External beam radiotherapy and brachytherapy in prostate cancer]. Laporte C; Larrouy A; Housset M Rev Prat; 2003 Dec; 53(20):2253-7. PubMed ID: 15018079 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T; Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219 [TBL] [Abstract][Full Text] [Related]